(Reuters) - Genentech had a profit of 78 cents per share for the quarter excluding stock-based compensation expenses and other items and posted total operating revenue of $3.0 billion, up from $2.2 billion a year ago. Both beat Wall Street forecasts.
Analysts, on average, had expected the South San Francisco-based company to post second-quarter earnings before items of 71 cents per share on revenue of $2.85 billion, according to Reuters Estimates.
Read more at Reuters.com Business News
Analysts, on average, had expected the South San Francisco-based company to post second-quarter earnings before items of 71 cents per share on revenue of $2.85 billion, according to Reuters Estimates.
Read more at Reuters.com Business News
No comments:
Post a Comment